CHK2 INHIBITOR II
|
|
- CAS-Nr.
- 516480-79-8
- Englisch Name:
- CHK2 INHIBITOR II
- Synonyma:
- C 3742;BML-277;CS-1761;BML-277, >98%;Chk2InhibitorⅡ;C 3742 BML-277;BML-277 (C 3742);Chk2 Inhibitor II hydrate;BML-277,CHK2 INHIBITOR II;Chk2 Inhibitor II (BML-277)
- CBNumber:
- CB9503256
- Summenformel:
- C20H14ClN3O2
- Molgewicht:
- 363.8
- MOL-Datei:
- 516480-79-8.mol
|
CHK2 INHIBITOR II Eigenschaften
- Siedepunkt:
- 637.1±63.0 °C(Predicted)
- Dichte
- 1.390±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: 18 mg/mL
- Aggregatzustand
- solid
- pka
- 10.40±0.10(Predicted)
- Farbe
- tan
- Stabilit?t:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P261 |
Einatmen von Staub vermeiden. |
P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
CHK2 INHIBITOR II Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Chk2 inhibitor II is a selective, ATP-competitive inhibitor of the DNA damage control kinase, checkpoint kinase 2 (IC
50 = 15 nM). It has been shown to prevent apoptosis in human T-cells exposed to ionizing radiation (EC
50 = 3-7.6 μM). This compound has been used to target the role of Chk2 in cellular signaling in response to DNA damage.
Verwenden
Chk2 Inhibitor II is a selective APT-competitive inhibitors of the DNA damage response signaling enzyme checkpoint kinase 2 (CHK2).
Biochem/physiol Actions
Chk2 Inhibitor II is a checkpoint kinase 2 inhibitor, which controls the p53 response to DNA breaks induced by radiation, leading to apoptosis. Protection of T-cells from apoptosis implies use as an adjuvant for radiation therapy in cancer. IC50 = 15 nM; Ki = 37 nM. Chk2 Inhibitor II shows 1000-fold greater selectivity for the Chk2 serine/threonine kinase than for the Cdk1/B and CK1 kinases (for which IC50 = 12 μM and 17 μM, respectively). Chk2 Inhibitor II weakly inhibits a panel of 31 other kinases (<25% inhibition at a concentration of 10 μM and prevents apoptosis of human CD4+ and CD8+ T-cells subjected to ionizing radiation (EC50 = 3 μM and 7.6 μM, respectively).
CHK2 INHIBITOR II Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
CHK2 INHIBITOR II Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 102)Lieferanten
516480-79-8()Verwandte Suche:
- C 3742
- BML-277
- 2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE
- 2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-5-carboxylic acid amide
- C 3742 BML-277
- InSolution? Chk2 Inhibitor II
- 2-[4-(4-chlorophenoxy)phenyl]-1H-benzimidazole-6-carboxamide
- 2-(4-(4-Chlorophenoxy)phenyl)-1H-benzimidazole-5-carboxamide hydrate
- Chk2 Inhibitor II hydrate
- 2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE, >98%
- BML-277, >98%
- BML-277 (C 3742)
- CS-1761
- BML-277,CHK2 INHIBITOR II
- CHK2 INHIBITOR II; C 3742; BML277; BML 277
- Chk2 Inhibitor II - CAS 516480-79-8 - Calbiochem
- InSolution Chk2 Inhibitor II - CAS 516480-79-8 - Calbiochem
- 2-[4-(4-chlorophenoxy)phenyl]-3H-benzimidazole-5-carboxamide
- Chk2 Inhibitor II (BML-277)
- 1H-Benzimidazole-6-carboxamide, 2-[4-(4-chlorophenoxy)phenyl]-
- 2-(4-(4-Chlorophenoxy)phenyl)-1H-benzo[d]imidazole-6-carboxamide
- inhibit,Checkpoint Kinase (Chk),Inhibitor,BML277,BML-277,Apoptosis
- Chk2InhibitorⅡ
- 516480-79-8
- Inhibitors
- API